TORRENT PHARMACEUTICALS LTD 23/06/2026 AGM
1To receive, consider and adopt the Standalone Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026For
2To receive, consider and adopt the Consolidated Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026For
3To confirm the payment of interim dividend on equity shares already paid during the financial year ended 31stMarch,2026 and to declare final dividend on equity shares for the said financial yearFor
4Elect Mr. Samir Mehta - Chair (Executive)Oppose
5Ratification Of Remuneration Of Cost Auditors Of The Company For The Year 2026-27 - M/s. Kirit Mehta & Co., Cost AccountantOppose
6Issuance Of Equity Shares Including Convertible Bonds / DebenturesFor